View in EDS

Further preclinical characterization of molnupiravir against SARS-CoV-2: Antiviral activity determinants and viral genome alteration patterns.

Saved in:
Bibliographic Details
Title: Further preclinical characterization of molnupiravir against SARS-CoV-2: Antiviral activity determinants and viral genome alteration patterns.
Authors: Petit PR; Unité des Virus Émergents (UVE: Aix-Marseille Univ, Università di Corsica, IRD 190, Inserm 1207, IRBA), France., Touret F; Unité des Virus Émergents (UVE: Aix-Marseille Univ, Università di Corsica, IRD 190, Inserm 1207, IRBA), France., Driouich JS; Unité des Virus Émergents (UVE: Aix-Marseille Univ, Università di Corsica, IRD 190, Inserm 1207, IRBA), France., Cochin M; Unité des Virus Émergents (UVE: Aix-Marseille Univ, Università di Corsica, IRD 190, Inserm 1207, IRBA), France., Luciani L; Unité des Virus Émergents (UVE: Aix-Marseille Univ, Università di Corsica, IRD 190, Inserm 1207, IRBA), France., Bernadin O; Unité des Virus Émergents (UVE: Aix-Marseille Univ, Università di Corsica, IRD 190, Inserm 1207, IRBA), France., Laprie C; Laboratoire Vet-Histo, Marseille, France., Piorkowski G; Unité des Virus Émergents (UVE: Aix-Marseille Univ, Università di Corsica, IRD 190, Inserm 1207, IRBA), France., Fraisse L; Drugs for Neglected Diseases Initiative, Geneva, Switzerland., Sjö P; Drugs for Neglected Diseases Initiative, Geneva, Switzerland., Mowbray CE; Drugs for Neglected Diseases Initiative, Geneva, Switzerland., Escudié F; Drugs for Neglected Diseases Initiative, Geneva, Switzerland., Scandale I; Drugs for Neglected Diseases Initiative, Geneva, Switzerland., Chatelain E; Drugs for Neglected Diseases Initiative, Geneva, Switzerland., de Lamballerie X; Unité des Virus Émergents (UVE: Aix-Marseille Univ, Università di Corsica, IRD 190, Inserm 1207, IRBA), France., Solas C; Unité des Virus Émergents (UVE: Aix-Marseille Univ, Università di Corsica, IRD 190, Inserm 1207, IRBA), France.; Laboratoire de Pharmacocinétique et Toxicologie, Hôpital La Timone, APHM, Marseille, France., Nougairède A; Unité des Virus Émergents (UVE: Aix-Marseille Univ, Università di Corsica, IRD 190, Inserm 1207, IRBA), France.
Source: Heliyon [Heliyon] 2024 May 08; Vol. 10 (10), pp. e30862. Date of Electronic Publication: 2024 May 08 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101672560 Publication Model: eCollection Cited Medium: Print ISSN: 2405-8440 (Print) Linking ISSN: 24058440 NLM ISO Abbreviation: Heliyon Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38803975
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Further preclinical characterization of molnupiravir against SARS-CoV-2: Antiviral activity determinants and viral genome alteration patterns.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Petit+PR%22">Petit PR</searchLink>; Unité des Virus Émergents (UVE: Aix-Marseille Univ, Università di Corsica, IRD 190, Inserm 1207, IRBA), France.<br /><searchLink fieldCode="AU" term="%22Touret+F%22">Touret F</searchLink>; Unité des Virus Émergents (UVE: Aix-Marseille Univ, Università di Corsica, IRD 190, Inserm 1207, IRBA), France.<br /><searchLink fieldCode="AU" term="%22Driouich+JS%22">Driouich JS</searchLink>; Unité des Virus Émergents (UVE: Aix-Marseille Univ, Università di Corsica, IRD 190, Inserm 1207, IRBA), France.<br /><searchLink fieldCode="AU" term="%22Cochin+M%22">Cochin M</searchLink>; Unité des Virus Émergents (UVE: Aix-Marseille Univ, Università di Corsica, IRD 190, Inserm 1207, IRBA), France.<br /><searchLink fieldCode="AU" term="%22Luciani+L%22">Luciani L</searchLink>; Unité des Virus Émergents (UVE: Aix-Marseille Univ, Università di Corsica, IRD 190, Inserm 1207, IRBA), France.<br /><searchLink fieldCode="AU" term="%22Bernadin+O%22">Bernadin O</searchLink>; Unité des Virus Émergents (UVE: Aix-Marseille Univ, Università di Corsica, IRD 190, Inserm 1207, IRBA), France.<br /><searchLink fieldCode="AU" term="%22Laprie+C%22">Laprie C</searchLink>; Laboratoire Vet-Histo, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Piorkowski+G%22">Piorkowski G</searchLink>; Unité des Virus Émergents (UVE: Aix-Marseille Univ, Università di Corsica, IRD 190, Inserm 1207, IRBA), France.<br /><searchLink fieldCode="AU" term="%22Fraisse+L%22">Fraisse L</searchLink>; Drugs for Neglected Diseases Initiative, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Sjö+P%22">Sjö P</searchLink>; Drugs for Neglected Diseases Initiative, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Mowbray+CE%22">Mowbray CE</searchLink>; Drugs for Neglected Diseases Initiative, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Escudié+F%22">Escudié F</searchLink>; Drugs for Neglected Diseases Initiative, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Scandale+I%22">Scandale I</searchLink>; Drugs for Neglected Diseases Initiative, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Chatelain+E%22">Chatelain E</searchLink>; Drugs for Neglected Diseases Initiative, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22de+Lamballerie+X%22">de Lamballerie X</searchLink>; Unité des Virus Émergents (UVE: Aix-Marseille Univ, Università di Corsica, IRD 190, Inserm 1207, IRBA), France.<br /><searchLink fieldCode="AU" term="%22Solas+C%22">Solas C</searchLink>; Unité des Virus Émergents (UVE: Aix-Marseille Univ, Università di Corsica, IRD 190, Inserm 1207, IRBA), France.; Laboratoire de Pharmacocinétique et Toxicologie, Hôpital La Timone, APHM, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Nougairède+A%22">Nougairède A</searchLink>; Unité des Virus Émergents (UVE: Aix-Marseille Univ, Università di Corsica, IRD 190, Inserm 1207, IRBA), France.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101672560%22">Heliyon</searchLink> [Heliyon] 2024 May 08; Vol. 10 (10), pp. e30862. <i>Date of Electronic Publication: </i>2024 May 08 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Ltd%22">Elsevier Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101672560 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2405-8440 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224058440%22">24058440 </searchLink><i>NLM ISO Abbreviation: </i>Heliyon <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38803975
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.heliyon.2024.e30862
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e30862
    Titles:
      – TitleFull: Further preclinical characterization of molnupiravir against SARS-CoV-2: Antiviral activity determinants and viral genome alteration patterns.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Petit PR
      – PersonEntity:
          Name:
            NameFull: Touret F
      – PersonEntity:
          Name:
            NameFull: Driouich JS
      – PersonEntity:
          Name:
            NameFull: Cochin M
      – PersonEntity:
          Name:
            NameFull: Luciani L
      – PersonEntity:
          Name:
            NameFull: Bernadin O
      – PersonEntity:
          Name:
            NameFull: Laprie C
      – PersonEntity:
          Name:
            NameFull: Piorkowski G
      – PersonEntity:
          Name:
            NameFull: Fraisse L
      – PersonEntity:
          Name:
            NameFull: Sjö P
      – PersonEntity:
          Name:
            NameFull: Mowbray CE
      – PersonEntity:
          Name:
            NameFull: Escudié F
      – PersonEntity:
          Name:
            NameFull: Scandale I
      – PersonEntity:
          Name:
            NameFull: Chatelain E
      – PersonEntity:
          Name:
            NameFull: de Lamballerie X
      – PersonEntity:
          Name:
            NameFull: Solas C
      – PersonEntity:
          Name:
            NameFull: Nougairède A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 08
              M: 05
              Text: 2024 May 08
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 2405-8440
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Heliyon
              Type: main
ResultId 1